SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OncoGenex Technologies Inc. Reports Updated Survival Data on OGX-011 in a Second-line Chemotherapy Trial for Patients with Prostate Cancer Updated Data to be Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology